Keywords: Lymphatic vessels; Lymphangiogenesis; Skeletal muscle; Exercise; Muscle disorders; VEGF-C; VEGF-D; VEGFR-3;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: VNP; viral nanoparticle; VLP; virus-like particle; CP; coat protein; TR; thrombin receptor; VEGFR-3; Vascular Endothelial Growth Factor 3; TuMV; Turnip mosaic virus; Viral nanoparticles; Peptide presentation; Thrombin receptor peptide; Antibody sensing; V
Keywords: Pancreatic cancer; Angiogenesis; Vascular endothelial growth factor (VEGF); ANGPT; angiopoietin; BRAF; serine/threonine-protein kinase B-raf; CAF; cancer associated fibroblast; Cdkn2a; cyclin-dependent kinase inhibitor 2A; CI; confidence interval; CSF1R;
Keywords: EPC; endothelial progenitor cell; ECFC; endothelial colony-forming cell; VEGF; vascular endothelial growth factor; Endothelial progenitor; Lymphatic endothelial progenitor; VEGFR-3; Prox-1;
Keywords: VEGF-C; VEGFR-3; LYVE-1; Prox-1; podoplanin; dry eye disease; corneal transplant; herpetic stromal keratitis; glaucoma; ocular tumor
CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling
Keywords: Lymphangiogenesis; CPT1A; VEGF-C and VEGF-D; VEGFR-3;
Impact of fenofibrate on choroidal neovascularization formation and VEGF-C plus VEGFR-3 in Brown Norway rats
Keywords: Brown Norway rats; Choroidal neovascularization; Fenofibrate; VEGFC; VEGFR-3;
VEGFR-3 signaling is regulated by a G-protein activator, activator of G-protein signaling 8, in lymphatic endothelial cells
Keywords: VEGFR-3; AGS8; G-protein; Lymphangiogenesis;
Immunoexpression of VEGFR-3, but not the immunoexpression of VEGF-C or lymphatic density, is correlated with metastasis in lower lip squamous cell carcinoma
Keywords: squamous cell carcinoma; lower lip; lymphangiogenesis; VEGF-C; VEGFR-3; immunohistochemistry;
Transcriptional regulation of podoplanin expression by Prox1 in lymphatic endothelial cells
Keywords: Prox1; prospero homeobox 1; PDPN; podoplanin; LEC; lymphatic endothelial cell; BEC; blood vessel endothelial cell; VEGFR-3; vascular endothelial growth factor receptor 3; Lyve-1; lymphatic vessel endothelial hyaluronan receptor 1; COUP-TFII; COUP transcri
Pathophysiological dilemmas of lipedema
Keywords: ADRF; adipocyte-derived relaxing factor; Ang-1,2; angiopoietin-1, 2; BMP-2; bone morphogenetic protein-2; CART; cocaine- and amphetamine-regulated transcript; ERα,β; estrogen receptor alpha, beta; HIF-1α; hypoxia-inducible factor-1 alpha; IPC; intermit
Restoration of natural killer cell cytotoxicity by VEGFR-3 inhibition in myelogenous leukemia
Keywords: VEGFR-3; Leukemia; Interferon-γ; Natural killer cell
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
Keywords: Advanced biliary tract cancer; BTC; Sorafenib; Hand-foot syndrome; VEGFR-2; VEGFR-3; c-kit; PDGFRβ; Hif1α;
ADAMTS1 inhibits lymphangiogenesis by attenuating phosphorylation of the lymphatic endothelial cell-specific VEGF receptor
Keywords: ADAMTS1; Lymphangiogenesis; VEGFC; VEGFR-3; Lymphatic endothelial cell;
Plant viral elongated nanoparticles modified for log-increases of foreign peptide immunogenicity and specific antibody detection
Keywords: Viral nanoparticles; Peptide presentation; VEGFR-3; Antibody; Detection;
Aberrant pulmonary lymphatic development in the nitrofen mouse model of congenital diaphragmatic hernia
Keywords: Lung lymphatic development; Prox-1; VEGFR-3; VEGF-D; LYVE-1; Nitrofen; Congenital diaphragmatic hernia; CDH; Chylothorax
N4-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-d]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: Design, synthesis, and in vivo evaluation
Keywords: ATP; adenosine 5â²triphosphate; VEGF; vascular endothelial growth factor; EGF; epidermal growth factor; PDGF; platelet derived growth factor; RTK; receptor tyrosine kinase; KDR; kinase insert domain receptor; VEGFR-2; vascular endothelial growth factor r
Immunohistochemical investigation of lymphatic vessel formation control in mouse tooth development: Lymphatic vessel-forming factors and receptors in tooth development in mice
Keywords: VEGF-C; VEGF-D; VEGFR-3; Lymphangiogenesis; Dental pulp; Odontoblastic layer
Distribution of vascular endothelial growth factor receptor-3/Flt4 mRNA in adult rat central nervous system
Keywords: VEGFR-3; Mapping; Brain; Spinal cord; Tanycytes; Hypothalamus; In situ hybridization;
Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma
Keywords: Lymphangiogenesis; VEGF-C; VEGFR-3; LYVE-1; Oral squamous cell carcinoma; Sentinel node
Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis
Keywords: COX-2; Eicosanoid; VEGF-C; VEGFR-3; Cancer
The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma
Keywords: Gastric carcinoma; VEGF-C; VEGFR-3; Lymphatic metastasis; Prognosis
Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face
Keywords: Cutaneous angiosarcoma; VEGF; VEGF-C; VEGFR-2; VEGFR-3;
The biological significance of lymphangiogenesis in human tumours
Keywords: cancer; lymphangiogenesis; lymphatic endothelial cells; lymphatic vessels; lymph nodes; metastasis; VEGF-C; VEGF-D; VEGFR-3
Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours
Keywords: VEGFR-1; VEGFR-2; VEGFR-3; EGFR; Angiogenesis inhibitors; Clinical trial; Phase I;
Gastrointestinal lymphatics in health and disease
Keywords: Interstitial fluid; Intestinal; Lymphatics; Inflammation; Vascular endothelial growth factors-C and D; VEGFR-3; Prox1; SOX18; FOXC2; Lymphedema
Tumor lymphatics
Keywords: Metastasis; Lymphangiogenesis; Lymphatic endothelial cells; Lymph node; Tumor dissemination; VEGF-C; VEGF-D; VEGFR-3
Decreased nerve distribution in mixed venous-lymphatic malformation
Keywords: vascular malformation; mixed venous-lymphatic malformation (MVLM); neurofilament(NF); VEGFR-3; infection;
Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-κB activation
Keywords: IL-1β; Lymphangiogenesis; Inflammation; VEGF-C; VEGF- D; VEGFR-3; Macrophage
Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas
Keywords: VEGF-C; VEGFR-3; Osteosarcoma
Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia
Keywords: VEGF-C; VEGFR-3; Acute myeloid leukaemia; Angiogenesis; Prognosis
Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma
Keywords: Breast cancer; Immunohistochemistry; VEGF-C; VEGF-D; VEGFR-3; Proliferation
Potential therapeutic strategies for lymphatic metastasis
Keywords: Ang; angiopoietins; COX-2; cyclooxygenase-2; EGF; epidermal growth factor; FGF-2; fibroblast growth factor-2, also called basic fibroblast growth factor; FGFR; fibroblast growth factor receptor; HGF; hepatocyte growth factor; IGF; insulin-like growth fact
Tumor-induced lymphangiogenesis: A target for cancer therapy?
Keywords: Lymphangiogenesis; Metastasis; VEGFR-3; VEGF-C; VEGF-D